A catalytic membrane reactor, which contains a membrane matrix and a catalytic film of alloy nanoparticle-loaded β-lactoglobulin fibrils (NPs@β-LGF), was developed for the continuous-flow reduction of 4-nitrophenol (4-NP). The Cu–Ag and Cu–Ag–Au alloy NPs were synthesized using β-LGF as a scaffold and stabilizing agent. In this process, the Cu nanoclusters were formed in the initial stage and were able to promote the synthesis of Ag 0, which acts as a reducing agent for the rapid formation of Au 0 . Furthermore, a catalytic membrane reactor was constructed by depositing the NPs@β-LGFs on a membrane matrix. The catalytic activity of the Cu–Ag–Au alloy NPs was higher than that of the Cu–Ag alloy NPs, using the reduction of 4-NP to 4-AP as a model reaction. The observed rate constant in the continuous-flow system is also higher than that in the batch system. In addition, these catalytic membrane reactors had good operating stability and antibacterial activity.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: